Abstract
Barrett's esophagus is present in approximately 10% of patients with gastroesophageal reflux disease. In this condition, the normal squamous epithelium of the esophagus is replaced by a metaplastic columnar (intestinal type) epithelium. Regarded as a precancerous lesion, adenocarcinoma will develop in as many as 10% of patients with Barrett's esophagus. Positron emission tomography with fluorodeoxyglucose (FDG PET) is used to detect various neoplasms. However, the detection of cancer and its precancerous lesion by FDG PET in the same patient has not been reported. The authors describe a patient in whom adenocarcinoma and its precancerous condition (Barrett's esophagus) were identified by FDG PET.
| Original language | English |
|---|---|
| Pages (from-to) | 1060 |
| Number of pages | 1 |
| Journal | Clinical Nuclear Medicine |
| Volume | 26 |
| Issue number | 12 |
| DOIs | |
| State | Published - 2001 |
| Externally published | Yes |
Keywords
- Adenocarcinoma
- Barrett's esophagus
- Fluorodeoxyglucose
- Positron emission tomography